Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue

Cancer Research

Volumn 65, Issue 18, 2005, Pages 8101-8110

  Karenko, Leena ^a,f   Hahtola, Sonja ^a   Päivinen, Suvi ^a   Karhu, Ritva ^b   Syrjä, Sanna ^a   Kähkönen, Marketta ^b   Nedoszytko, Boguslaw ^d   Kytölä, Soili ^b   Zhou, Ying ^a   Blazevic, Vesna ^c   Pesonen, Maria ^a   Nevala, Hanna ^a   Nupponen, Nina ^a   Sihto, Harri ^a   Krebs, Inge ^e   Poustka, Annemarie ^e   Roszkiewicz, Jadwiga ^d   Saksela, Kalle ^b   Peterson, Pärt ^b   Visakorpi, Tapio ^b   Ranki, Annamari ^a   more..

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c FIT Biotech Plc   (Finland)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; SMALL INTERFERING RNA;

ALLELE; APOPTOSIS; ARTICLE; CAENORHABDITIS ELEGANS; CANCER GROWTH; CANCER STAGING; CELL DIFFERENTIATION; CHROMOSOME 12Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME MAP; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; EARLY CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; GENE TRANSLOCATION; HAPLOTYPE; HUMAN; HUMAN CELL; LENTIVIRINAE; LEUKEMIA CELL LINE; MISSENSE MUTATION; MONOSOMY; MYCOSIS FUNGOIDES; NAV3 GENE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SEZARY SYNDROME; TH1 CELL; TH2 CELL; TUMOR SUPPRESSOR GENE; UNC 53 GENE;

ALLELES; CHROMOSOME ABERRATIONS; CHROMOSOME BREAKAGE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; GENE DELETION; GENE SILENCING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERLEUKIN-2; INTERPHASE; LYMPHOMA, T-CELL, CUTANEOUS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; SEZARY SYNDROME; SKIN NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 24944483636     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0366     Document Type: Article

References (52)

1. Willemze R, Jaffe E, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas, Blood 2005;15:3768-85.
2. Weinstock MA, Horm JW. Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA 1988;260:42-6.
3. Väkevä L, Pukkala E, Ranki A. Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma. J Invest Dermatol 2000;115:62-5.
4. Rowley JD. The critical role of chromosome translocations in human leukemias. Annu Rev Genet 1998;32:495-519.
5. Vega F, Orduz R, Medeiros LJ. Chromosomal translocations and their role in the pathogenesis of non-Hodgkin's lymphomas. Pathology 2002;34:397-409.
6. Whang-Peng J, Bunn PA, Knutsen T, Matthews MJ, Schechter G, Minna JD. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer 1982;50;1539-53.
7. Karenko L, Hyytinen E, Sarna S, Ranki A. Chromosomal abnormalities in cutaneous T-cell lymphoma (CTCL) and its premalignant conditions as detected by G-banding and interphase cytogenetic methods. J Invest Dermatol 1997;108:22-9.
8. Karenko L, Kähkönen M, Hyytinen E-R, Lindlöf M, Ranki A. Notable losses at specific regions of chromosomes 10q and 13q in the Sézary syndrome detected by comparative genomic hybridization. J Invest Dermatol 1999;112:392-5.
9. Mao X, Lillington DM, Czepulkowski B, Russell-Jones R, Young BD, Whittaker S. Molecular cytogenetic characterization of Sézary syndrome. Genes Chromosomes Cancer 2003;36:250-60.
10. Karenko L, Sarna S, Kähkönen M, Ranki A. Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T-cell lymphoma: a 5-year follow-up study. Br J Dermatol 2003;148:55-64.
11. Karenko L, Nevala H, Raatikainen M, Franssila K, Ranki A. Chromosomally clonal T cells in the skin, blood or lymph nodes of two Sézary syndrome patients express CD45RA, CD45RO, CDw150, and interleukin-4, but no interleukin-2 or interferon-γ. J Invest Dermatol 2001;116:188-93.
12. ISCN. An international system for human cytogenetic nomenclature. In: Mitelman F, editor. Basel (Switzerland): S. Karger; 1995.
13. Zhang KZ, Westberg JA, Holtta E, Andersson LC. BCL2 regulates neural differentiation. Proc Natl Acad Sci U S A 1996;93:4504-8.
14. Coy JF, Wiemann S, Bechmann I, et al. Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms. Gene 2002;290:73-94.
15. Schröck E, du Manoir S, Veldman T, et al. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494-7.
16. Speicher MR, Gwyn Ballard S, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 1996;12:368-75.
17. Hyytinen E, Visakorpi T, Kallioniemi A, Kallioniemi OP, Isola JJ. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry 1994;16:93-9.
18. Sihto H, Sarlomo-Rikala M, Tynninen O, et al. KIT and platelet-derived growth factor receptor α tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J Clin Oncol 2005;23:49-57.
19. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997;15:871-5.
20. Linja MK, Porkka KP, Kang KJ, et al. Expression of androgen receptor coregulators in prostate cancer. Clin Cancer Res 2004;10:1032-40.
21. Higgins, MJ, Hansen HF, Cavenee WK, Lalande M. Molecular detection of chromosomal translocations that disrupt the putative retinoblastoma susceptibility locus. Mol Cell Biol 1989;9:1-5.
22. Maes T, Barceló A, Buesa C. Neuron navigator: a human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans. Genomics 2002;80:21-30.
23. Merrill RA, Plum LA, Kaiser ME, Clagett-Dame M. A mammalian homolog of unc-53 is regulated by all-trans retinoic acid in neuroblastoma cells and embryos. Proc Natl Acad Sci U S A 2002;99:3422-7.
24. Stringham E, Pujol N, Vandekerckhove J, Bogaert T. unc53 controls longitudinal migration in C elegans. Development 2002;129:3367-79.
25. Rao J, Li N. Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Targets 2004;4:345-54.
26. Fahrenkrog B, Aebi U. The nuclear pore complex: nucleocytoplasmic transport and beyond. Nat Rev Mol Cell Biol 2003;4:757-66.
27. Ishiguro H, Shimokawa T, Tsunoda T, et al. Isolation of HELAD1, a novel human helicase gene up-regulated in colorectal carcinomas. Oncogene 2002;21:6387-94.
28. Nakayama H. RecQ family helicases: roles as tumor suppressor proteins [review]. Oncogene 2002;21:9008-21.
29. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. Loss of heterozygosity on 10q and microsatelite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 2000;95:2937-42.
30. Limon J, Nedoszytko B, Brozek I, et al. Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocyte of five cases with Sézary syndrome. Cancer Genet Cytogenet 1995;83:75-81.
31. Kaltoft K, Hansen BH, Thestrup-Pedersen K. Cytognetic findings in cell lines from cutaneous T-cell lymphoma. Dermatol Clin 1994;12:295-304.
32. Hickson ID. RecQ Helicases: Caretakers of the genome. Review. Nat Rev Cancer 2003;3:169-78.
33. Sherr CJ. Principles of tumor suppression. Review. Cell 2004;116:235-46.
34. Peeters PJ, Baker A, Goris I, et al. Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53. Dev Brain Res 2004;150:89-101.
35. Navas IC, Ortiz-Romero PL, Villuendas R, et al. p16INK4a gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol 2000;156:1565-72.
36. Garatti SA, Roscetti E, Trecca D, Fracciolla NS, Neri A, Berti E. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous T-cell lymphomas. Recent Results Cancer Res 1995;139:249-61.
37. Scarisbrick JJ, Woolford AJ, Calonje E, et al. Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and Sézary syndrome. J Invest Dermatol 2002;118:493-9.
38. Mao X, Lillington D, Scarisbrick JJ, et al. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: Identification of common genetic alterations in Sézary syndrome and mycosis fungoides. Br J Dermatol 2002;147:464-75.
39. Smith KA. Interleukin-2: inception, impact, and implications. Science 1988;240:1169-76.
40. Saed G, Fivenson DP, Naidu Y, Nickoloff BJ. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sézary syndrome expresses a Th2-type profile. J Invest Dermatol 1994;103:29-33.
41. Lee BN, Duvic M, Tang CK, et al. Dysregulated synthesis of intracellular type 1 and type 2 cytokine by T cells of patients with cutaneous T-cell lymphoma. Clin Diagn Lab Immunol 1999:1:79-84.
42. Cote-Sierra J, Foucras G, Guo L, et al. Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci U S A 2005;101:3880-5.
43. Jones D, Ibrahim S, Patel K, Luthra R, Duvic M, Medeiros LJ. Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy. Clin Cancer Res 2004;10:5587-94.
44. Mitchell TJ, Whittaker SJ, John S. Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sézary syndrome. Cancer Res 2003;63:9048-54.
45. Eriksen KW, Kaltoft K, Mikkelsen G, et al. Constitutive STAT3-activation in Sézary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sézary cells. Leukemia 2001;15:787-93.
46. Moriggl R, Topham DJ, Teglund S, et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 1999;10:249-59.
47. Nakajima H, Liu XW, Wynshaw-Boris A, et al. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-medated IL-2 receptor α chain induction. Immunity 1997;7:691-701.
48. Frauwirth KA, Thompson GB. Activation and inhibition of lymphocytes by costimulation [review]. J Clin Invest 2002;109:295-9.
49. Moghal N, Sternberg PW. The epidermal growth factor system in Caenorhabditis elegans. Exp Cell Res 2003;284:150-9.
50. Fraser-Andrews EA, Woolford AJ, Russell-Jones R, Seed PT, Whittaker SJ. Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 2000;114:117-21.
51. Lukowsky A, Muche JM, Sterry W, Audring H. Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor γ polymerase chain reaction assay, J Invest Dermatol 2000;115:254-9.
52. Muche JM, Karenko L, Gellrich S, et al. Cellular coincidence of clonal T-cell receptor rearrangements and complex clonal chromosomal aberrations-a hallmark of malignancy in cutaneous T-cell lymphoma? J Invest Dermatol 2004;122:574-8.